top of page

Comfort Through Innovation: Supporting Patients in Cancer Radiotherapy

Radiotherapy for head and neck cancer, whether photon, proton, or heavy-ion, often triggers severe oral mucositis. These painful ulcers can force patients to reduce dose, stretch treatment intervals, or even interrupt therapy, compromising outcomes and quality of life.🥲

🚀 On Nov 6, our team visited Yuan's General Hospital (阮綜合醫院) in Kaohsiung to introduce MuCover Oral Wound Dressing. We are deeply grateful to the physicians, nurses, and allied health professionals who shared valuable frontline perspectives on mucositis care and patient comfort.


At MoleculeX, we are proud to develop the world's first large-area wound dressing patch made specifically for the oral mucosa. We will keep striving to make this innovation available to more cancer patients and help them face treatment with greater comfort. 😊



 
 
 

最新文章

查看全部
🚀 Exciting News!

💪 We're honored to share that MoleculeX has been ranked 13 Biotech Company in Taiwan on F6S this January 2026. Compared to last year, we've reached several important milestones. More hospitals in Tai

 
 
 

留言


© 2021-2025 MoleculeX Co., Ltd. All right reserved.

bottom of page